Sunday, December 17, 2017

ITUS Corporation Terminates At-The-Market Offering

Tailwinds' Take: I love it when companies decide not to dilute their investors. ITUS' model is one of partnerships and joint-ventures. This is very...

ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent

SAN JOSE, Calif., Nov. 28, 2017 /PRNewswire/ -- ITUS Corporation (NASDAQ: ITUS), a company using the power of the immune system to diagnose and treat...

ITUS: an Exciting Cancer Story, Part 2(b)

On November 13, ITUS Corporation announced that they had licensed a cancer therapy from the Wistar Institute, a Philadelphia based biomedical research organization. In doing...

ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center

Tailwinds' Take: this is a big deal for ITUS as Moffitt is one of the preeminent cancer research centers in the US and their...

What Is A.I.??? And, Four Ways To Invest In It.

In the twenty-first century, AI techniques have experienced a massive surge in interest following concurrent advances in computer power, large amounts of data, and theoretical understanding....

ITUS Corporation Licenses CAR-T Technology from The Wistar Institute

Tailwinds' Take: While there remains a lot of work to be done, the pre-clinical work to date has yielded excellent results. Progress in attacking...

ITUS: an Exciting Cancer Story, Part 2(a)

A recent addition to the Tailwinds Select Portfolio, ITUS Corporation is a compelling young biotech startup located in San Jose. Led by Dr. Amit...

ITUS: An Exciting Cancer Story, Part 1

In the 1st of this two-part series, we examine ITUS’ work with its lead product, Cchek, a revolutionary cancer diagnostic. In part 2 we...

ITUS Corporation Pays Off Secured Debenture

SAN JOSE, CA -- (Marketwired) -- 10/27/17 -- ITUS Corporation (NASDAQ: ITUS) today announced that it has satisfied all obligations under its secured debenture by paying...

ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer

SAN JOSE, CA -- (Marketwired) -- 09/21/17 -- ITUS Corporation (NASDAQ: ITUS) today provides a corporate update before its Annual Meeting of Stockholders to be held...

ITUS Corporation Announces Issuance of Patent on Cancer Detection Technology

SAN JOSE, CA -- (Marketwired) -- 09/18/17 -- ITUS Corporation (NASDAQ: ITUS), today announced that the United States Patent and Trademark Office ("USPTO") has issued...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address